TK
Tejas Kansal
About Tejas Kansal
Data last updated:
Tejas Kansal has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Mediere Pharmaceuticals Private Limited and Apotekare Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹2.14 Cr; the largest is Mediere Pharmaceuticals Private Limited at ₹2.10 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Apr 2023 | 2023 | ₹2.10 Cr (FY 2024) | Active | |
| Director | 23 Aug 2021 | 2021 | ₹0.04 Cr (FY 2022) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tejas Kansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tejas Kansal
Tejas Kansal has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Mediere Pharmaceuticals Private Limited and Apotekare Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹2.14 Cr; the largest is Mediere Pharmaceuticals Private Limited at ₹2.10 Cr (FY 2024).
Tejas Kansal is associated with 2 companies as Director, including Mediere Pharmaceuticals Private Limited (₹2.10 Cr), Apotekare Lifesciences Private Limited (₹0.04 Cr).
Tejas Kansal has expertise in General Business.
Tejas Kansal has 5 years in corporate governance.
By reported revenue, the largest current company of Tejas Kansal is Mediere Pharmaceuticals Private Limited, with revenue of ₹2.10 Cr (FY 2024).
The 2 current companies of Tejas Kansal that report revenue have a combined latest revenue of ₹2.14 Cr.
Tejas Kansal currently holds positions at 2 companies: Mediere Pharmaceuticals Private Limited (₹2.10 Cr), Apotekare Lifesciences Private Limited (₹0.04 Cr).